{"id":1002,"date":"2025-12-04T05:50:43","date_gmt":"2025-12-04T05:50:43","guid":{"rendered":"http:\/\/eurosoi.org\/?p=1002"},"modified":"2025-12-04T05:50:43","modified_gmt":"2025-12-04T05:50:43","slug":"c-mean-number-of-langerincells-in-foreskin-epithelium-standard-deviation-at-each-anatomic-site","status":"publish","type":"post","link":"https:\/\/eurosoi.org\/?p=1002","title":{"rendered":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site"},"content":{"rendered":"<p>\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site. The total numbers and distribution of CD3+cells BRL 37344 Na Salt in foreskin proved comparable in baseline and vaccinated animals in both groups regardless of baseline Ad5 immunity (Fig.5b). without baseline Ad5 immunity. Moreover, the total cellular inflammatory infiltrates and the CD3+, CD4+, HLA-DR+, Ki67+, and langerin+cellular subpopulations in colorectal and foreskin mucosa were similar in both groups. Thus, no greater trafficking of Ad5-specific CD4+T lymphocytes to mucosal target sites was observed following rAd5 vaccination of rhesus monkeys with baseline Ad5 immunity. These findings from this nonhuman primate model provide evidence against the hypothesis that recruitment of vector-specific target cells to mucosal sites led to increased HIV-1 acquisition in Ad5-seropositive, uncircumcised vaccinees in the Step study. The Step study revealed a potential increased risk of HIV-1 acquisition among adenovirus serotype 5 (Ad5)-seropositive, uncircumcised subjects who received the Merck recombinant Ad5 (rAd5)-Gag\/Pol\/Nef vaccine candidate (2,6). It has been hypothesized that rAd5 vaccination of Ad5-seropositive individuals may have resulted in robust expansion and activation of vector-specific CD4+T lymphocytes that could have trafficked to mucosal sites and served as increased targets for HIV-1 infection. Our laboratory and others have recently demonstrated that <a href=\"http:\/\/mn.essortment.com\/howtoopenswis_rjiw.htm\">Rabbit Polyclonal to CCT7<\/a> total and vector-specific CD4+T lymphocytes in peripheral blood in Ad5-seropositive volunteers were comparable to or lower than the levels in Ad5-seronegative volunteers following rAd5-Gag vaccination in the Merck phase 1 studies (4,8). However, mucosal biopsy specimens were not obtained in these clinical trials, and thus the extent of inflammatory infiltrates and vector-specific CD4+T lymphocytes in colorectal and foreskin mucosa could not be evaluated in these prior studies. It has also recently been reported that vector-specific CD4+T lymphocytes may upregulate mucosal homing integrin expression following exposure to Ad5 in short-termin vitrocultures (1). These findings highlight the importance of directly investigating the extent and nature of vector-specific CD4+T lymphocytes at mucosal sites following rAd5 vaccination. Given the lack of mucosal biopsy samples from human BRL 37344 Na Salt subjects in the Step study, we developed a nonhuman primate model of preexisting adenovirus immunity to evaluate the extent and nature of inflammatory cell populations at mucosal sites following rAd5 vaccination. == MATERIALS AND METHODS == == Animals and immunizations. == Adult Indian-origin rhesus monkeys (n= 12) were housed in the biosafety level 3 containment facility at the New England Primate Research Center (NEPRC), and all studies were approved by the Harvard Medical School Institutional Animal Care and Use <a href=\"https:\/\/www.adooq.com\/brl-37344-na-salt.html\">BRL 37344 Na Salt<\/a> Committee (IACUC). Baseline BRL 37344 Na Salt endoscopic biopsy specimens of the colorectum and snip biopsy specimens of inner penile foreskin (IPF) were collected prior to inoculation. Animals were inoculated twice at an interval of 4 weeks by the intranasal route with either 1011viral particles of replication-competent Ad5 containing host range mutations (n= 6) or saline (n= 6). After 4 weeks, animals were vaccinated by the intramuscular route with 1011viral particles of replication-incompetent, E1-\/E3-deleted rAd5-Gag\/Pol\/Nef vectors in the quadriceps muscles. Of note, replication-incompetent, E1-deleted rAd5-Gag\/Pol\/Nef vectors were utilized in the Step study. Animals were sacrificed 2 weeks after vaccination, and a full necropsy was performed. == Isolation of mucosal lymphocytes. == Colorectal biopsy specimens in RPMI 1640 medium containing 10% fetal bovine serum supplemented with 300 U\/ml of type IV collagenase (Sigma-Aldrich) and 30 U\/ml of DNase I (Sigma) were incubated at 37C with rocking for 30 min. The digested biopsy tissues were then homogenized, and the solution was strained with a 70-m cell strainer (BD Falcon). The cell suspension was then centrifuged at 1,800 rpm for 25 min on a 35% Percoll gradient (Sigma). Pellets containing the lymphocytes were collected and processed for intracellular cytokine staining. Colorectal tissue specimens obtained at necropsy were cut into pieces of similar size to the biopsy specimens and were then processed similarly. == BRL 37344 Na Salt Ad5-specific IFN- ELISPOT assays. == Ad5-specific gamma interferon (IFN-) enzyme-linked immunospot (ELISPOT) assays were conducted essentially as described previously (4,8). Peripheral blood mononuclear cells (PBMC) were stimulated by replication-incompetent Ad5 virus (104multiplicity of infection) or by pooled overlapping peptides covering the Ad5 E2A or Ad5 hexon protein.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site. The total numbers and distribution of CD3+cells BRL 37344 Na Salt in foreskin proved comparable in baseline and vaccinated animals in both groups regardless of baseline Ad5 immunity (Fig.5b). without baseline Ad5 immunity. Moreover, the total <a href=\"https:\/\/eurosoi.org\/?p=1002\" class=\"btn btn-link continue-link\">Continue Reading<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-1002","post","type-post","status-publish","format-standard","hentry","category-kop-receptors"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site - JAK2 inhibitor against human prostate cancer cells<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurosoi.org\/?p=1002\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site - JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"og:description\" content=\"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site. The total numbers and distribution of CD3+cells BRL 37344 Na Salt in foreskin proved comparable in baseline and vaccinated animals in both groups regardless of baseline Ad5 immunity (Fig.5b). without baseline Ad5 immunity. Moreover, the total Continue Reading\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurosoi.org\/?p=1002\" \/>\n<meta property=\"og:site_name\" content=\"JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-04T05:50:43+00:00\" \/>\n<meta name=\"author\" content=\"info\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002\"},\"author\":{\"name\":\"info\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"headline\":\"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site\",\"datePublished\":\"2025-12-04T05:50:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002\"},\"wordCount\":703,\"articleSection\":[\"KOP Receptors\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002\",\"name\":\"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site - JAK2 inhibitor against human prostate cancer cells\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\"},\"datePublished\":\"2025-12-04T05:50:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurosoi.org\\\/?p=1002\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=1002#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurosoi.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/\",\"name\":\"JAK2 inhibitor against human prostate cancer cells\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurosoi.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\",\"name\":\"info\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"caption\":\"info\"},\"sameAs\":[\"http:\\\/\\\/eurosoi.org\"],\"url\":\"https:\\\/\\\/eurosoi.org\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site - JAK2 inhibitor against human prostate cancer cells","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurosoi.org\/?p=1002","og_locale":"en_US","og_type":"article","og_title":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site - JAK2 inhibitor against human prostate cancer cells","og_description":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site. The total numbers and distribution of CD3+cells BRL 37344 Na Salt in foreskin proved comparable in baseline and vaccinated animals in both groups regardless of baseline Ad5 immunity (Fig.5b). without baseline Ad5 immunity. Moreover, the total Continue Reading","og_url":"https:\/\/eurosoi.org\/?p=1002","og_site_name":"JAK2 inhibitor against human prostate cancer cells","article_published_time":"2025-12-04T05:50:43+00:00","author":"info","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurosoi.org\/?p=1002#article","isPartOf":{"@id":"https:\/\/eurosoi.org\/?p=1002"},"author":{"name":"info","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"headline":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site","datePublished":"2025-12-04T05:50:43+00:00","mainEntityOfPage":{"@id":"https:\/\/eurosoi.org\/?p=1002"},"wordCount":703,"articleSection":["KOP Receptors"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurosoi.org\/?p=1002","url":"https:\/\/eurosoi.org\/?p=1002","name":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site - JAK2 inhibitor against human prostate cancer cells","isPartOf":{"@id":"https:\/\/eurosoi.org\/#website"},"datePublished":"2025-12-04T05:50:43+00:00","author":{"@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"breadcrumb":{"@id":"https:\/\/eurosoi.org\/?p=1002#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurosoi.org\/?p=1002"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eurosoi.org\/?p=1002#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurosoi.org\/"},{"@type":"ListItem","position":2,"name":"\ufeff(c) Mean number of langerin+cells in foreskin epithelium standard deviation at each anatomic site"}]},{"@type":"WebSite","@id":"https:\/\/eurosoi.org\/#website","url":"https:\/\/eurosoi.org\/","name":"JAK2 inhibitor against human prostate cancer cells","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurosoi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd","name":"info","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","caption":"info"},"sameAs":["http:\/\/eurosoi.org"],"url":"https:\/\/eurosoi.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/1002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1002"}],"version-history":[{"count":1,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/1002\/revisions"}],"predecessor-version":[{"id":1003,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/1002\/revisions\/1003"}],"wp:attachment":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}